In the xenotransplantation model, MEG3 overexpression promotes angiogenesis of breast cancer cells, while decreased phosphorylated AKT levels inhibit downstream angiogenesis-related factors VEGFA and TGF-β9.153. This evidence concerns the gene AKT1 and breast carcinoma.